Skip to main content

BNP PARIBAS ARBITRAGE, SA

Position in GRAL — GRAIL, Inc.

CIK 1166588 NEW YORK, NY

Position in GRAL

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$7,688,692
+$6,028,418 QoQ
Shares Held
148,775
+667.0% QoQ
Ownership
0.347%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in GRAL Over Time

Shares Held

Position Value (USD)

Derivatives in GRAL

reported options exposure · as of Mar 31, 2026
CallValue
$23,256
CallShares
450
PutValue
$28,424
PutShares
550

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

BNP PARIBAS ARBITRAGE, SA holds $1,383,399,743 across 39 Diagnostics & Research names. GRAL ranks #19 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GRAL

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $23,256 450
2026-03-31 $28,424 550
2026-03-31 $7,688,692 148,775
2025-12-31 $1,660,274 19,398
2025-09-30 $839,409 14,196
2025-06-30 $1,341,239 26,084
2025-03-31 $299,354 11,721
2024-12-31 $50,337 2,820
2024-09-30 $399,507 29,034
2024-06-30 $501,231 32,611